Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2441-2449

  Takahashi, Masanobu ^a   Sung, Bokyung ^b   Shen, Yan ^a   Hur, Keun ^a   Link, Alexander ^a   Boland, C Richard ^a   Aggarwal, Bharat B ^b   Goel, Ajay ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSWELLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 200; MICRORNA LET 7; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B; TRITERPENES;

EID: 84870364798     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs286     Document Type: Article

References (46)

1. Jemal, A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277-300.
2. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
3. Calin, G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
4. Garzon, R. et al. (2009) MicroRNAs in Cancer. Annu. Rev. Med., 60, 167-179.
5. Peter, M.E. (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle, 8, 843-852.
6. Boyerinas, B. et al. (2010) The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer, 17, F19-F36.
7. Johnson, S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
8. Sampson, V.B. et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 67, 9762-9770.
9. Legesse-Miller, A. et al. (2009) let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts. J. Biol. Chem., 284, 6605-6609.
10. Johnson, C.D. et al. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 67, 7713-7722.
11. Lee, Y.S. et al. (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 21, 1025-1030.
12. Kiriakidou, M. et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev., 18, 1165-1178.
13. Takamizawa, J. et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753-3756.
14. Iorio, M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
15. Motoyama, K. et al. (2008) Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin. Cancer Res., 14, 2334-2340.
16. Gregory, P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
17. Park, S.M. et al. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev., 22, 894-907.
18. Tellez, C.S. et al. (2011) EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res., 71, 3087-3097.
19. Bader, A.G. et al. (2010) The promise of microRNA replacement therapy. Cancer Res., 70, 7027-7030.
20. Garzon, R. et al. (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov., 9, 775-789.
21. Shah, B.A. et al. (2009) Boswellic acids: a group of medicinally important compounds. Nat. Prod. Rep., 26, 72-89.
22. Moussaieff, A. et al. (2009) Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J. Pharm. Pharmacol., 61, 1281-1293.
23. Safayhi, H. et al. (1992) Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther., 261, 1143-1146.
24. Safayhi, H. et al. (1995) Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol. Pharmacol., 47, 1212-1216.
25. Glaser, T. et al. (1999) Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer, 80, 756-765.
26. Liu, J.J. et al. (2002) Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis, 23, 2087-2093.
27. Liu, J.J. et al. (2006) Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br. J. Pharmacol., 148, 1099-1107.
28. Lu, M. et al. (2008) Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Cancer Res., 68, 1180-1186.
29. Pang, X. et al. (2009) Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res., 69, 5893-5900.
30. Hostanska, K. et al. (2002) Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res., 22, 2853-2862.
31. Yadav, V.R. et al. (2012) Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int. J. Cancer, 130, 2176-2184.
32. Park, B. et al. (2011) Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int. J. Cancer, 129, 23-33.
33. Takada, Y. et al. (2006) Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J. Immunol., 176, 3127-3140.
34. Kunnumakkara, A.B. et al. (2009) Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol. Cancer Res., 7, 118-128.
35. Takahashi, M. et al. (2011) MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor. J. Biol. Chem., 286, 12157-12165.
36. Yu, F. et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123.
37. Yang, N. et al. (2008) MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res., 68, 10307-10314.
38. Li, Y. et al. (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res., 69, 6704-6712.
39. Lu, L. et al. (2007) Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res., 67, 10117-10122.
40. Weidhaas, J.B. et al. (2007) MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res., 67, 11111-11116.
41. King, C.E. et al. (2011) LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene, 30, 4185-4193.
42. Blower, P.E. et al. (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol. Cancer Ther., 7, 1-9.
43. Davalos, V. et al. (2012) Dynamic epigenetic regulation of the micro-RNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene, 31, 2062-2074.
44. Chen, X.M. et al. (2007) A cellular micro-RNA, let-7i, regulates Tolllike receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem., 282, 28929-28938.
45. O'Hara, S.P. et al. (2010) NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J. Biol. Chem., 285, 216-225.
46. Wang, Z. et al. (2011) Pancreatic cancer: understanding and overcoming chemoresistance. Nat. Rev. Gastroenterol. Hepatol., 8, 27-33.